species_id,stId,name,FDR,entities_tot,entities_found,reactions_tot,reactions_found
9606,R-HSA-156902,Peptide chain elongation,8.770761894538737e-15,97,21,5,5
9606,R-HSA-5663205,Infectious disease,8.770761894538737e-15,1962,97,1225,137
9606,R-HSA-9839923,Dengue Virus Infection,8.770761894538737e-15,411,43,142,21
9606,R-HSA-9918481,Dengue Virus-Host Interactions,8.770761894538737e-15,274,35,59,9
9606,R-HSA-9010553,Regulation of expression of SLITs and ROBOs,8.770761894538737e-15,170,26,20,5
9606,R-HSA-8953897,Cellular responses to stimuli,8.770761894538737e-15,1166,65,613,159
9606,R-HSA-2262752,Cellular responses to stress,8.770761894538737e-15,1039,64,521,148
9606,R-HSA-8953854,Metabolism of RNA,8.770761894538737e-15,862,65,244,88
9606,R-HSA-9824446,Viral Infection Pathways,8.770761894538737e-15,1404,90,897,108
9606,R-HSA-156827,L13a-mediated translational silencing of Ceruloplasmin expression,8.770761894538737e-15,120,23,3,2
9606,R-HSA-72187,mRNA 3'-end processing,8.770761894538737e-15,164,26,21,18
9606,R-HSA-156842,Eukaryotic Translation Elongation,8.770761894538737e-15,102,23,9,8
9606,R-HSA-9948299,Ribosome-associated quality control,8.770761894538737e-15,155,25,20,20
9606,R-HSA-72706,GTP hydrolysis and joining of the 60S ribosomal subunit,8.770761894538737e-15,120,23,3,3
9606,R-HSA-392499,Metabolism of proteins,8.770761894538737e-15,2430,99,929,400
9606,R-HSA-72689,Formation of a pool of free 40S subunits,8.770761894538737e-15,106,22,2,2
9606,R-HSA-72737,Cap-dependent Translation Initiation,1.554312234475219e-14,130,23,18,13
9606,R-HSA-72613,Eukaryotic Translation Initiation,1.554312234475219e-14,130,23,21,15
9606,R-HSA-376176,Signaling by ROBO receptors,4.39648317751562e-14,222,28,60,7
9606,R-HSA-9770562,mRNA Polyadenylation,6.294964549624638e-14,139,23,20,17
9606,R-HSA-3214847,HATs acetylate histones,7.327471962526033e-14,110,21,15,13
9606,R-HSA-9954714,PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA,1.4555023852835802e-13,100,20,3,3
9606,R-HSA-975956,Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),1.6486811915683575e-13,101,20,1,1
9606,R-HSA-1643685,Disease,2.020605904817785e-13,3093,110,2167,290
9606,R-HSA-9837999,Mitochondrial protein degradation,2.55351295663786e-13,104,20,20,8
9606,R-HSA-9954716,ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA,2.9309887850104133e-13,105,20,4,4
9606,R-HSA-72764,Eukaryotic Translation Termination,3.3706371027619753e-13,106,20,5,3
9606,R-HSA-927802,Nonsense-Mediated Decay (NMD),5.25135490647699e-13,124,21,6,5
9606,R-HSA-975957,Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),5.25135490647699e-13,124,21,5,4
9606,R-HSA-2408557,Selenocysteine synthesis,8.43991543320044e-13,112,20,7,2
9606,R-HSA-192823,Viral mRNA Translation,1.1102230246251565e-12,114,20,2,2
9606,R-HSA-168255,Influenza Infection,1.1647349751342517e-12,200,25,61,9
9606,R-HSA-9633012,Response of EIF2AK4 (GCN2) to amino acid deficiency,1.2361223156176493e-12,115,20,16,4
9606,R-HSA-72766,Translation,1.404876215360673e-12,450,36,126,64
9606,R-HSA-9692914,SARS-CoV-1-host interactions,1.8745005547771143e-12,118,20,48,11
9606,R-HSA-1799339,SRP-dependent cotranslational protein targeting to membrane,2.125521980644862e-12,119,20,5,5
9606,R-HSA-72203,Processing of Capped Intron-Containing Pre-mRNA,3.132494263979879e-12,317,30,52,48
9606,R-HSA-168273,Influenza Viral RNA Transcription and Replication,3.132494263979879e-12,173,23,14,5
9606,R-HSA-8868773,rRNA processing in the nucleus and cytosol,1.5411671938636573e-11,207,24,15,9
9606,R-HSA-72649,Translation initiation complex formation,1.706301766546403e-11,62,15,2,2
9606,R-HSA-6791226,Major pathway of rRNA processing in the nucleolus and cytosol,1.706301766546403e-11,189,23,7,6
9606,R-HSA-9735869,SARS-CoV-1 modulates host translation machinery,2.1985746556651975e-11,41,13,3,2
9606,R-HSA-72702,Ribosomal scanning and start codon recognition,2.5708879469732437e-11,64,15,2,2
9606,R-HSA-72662,"Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S",3.8192560225525085e-11,66,15,6,5
9606,R-HSA-72695,"Formation of the ternary complex, and subsequently, the 43S complex",3.83169052042831e-11,54,14,3,1
9606,R-HSA-1640170,Cell Cycle,2.8758095904635184e-10,729,42,474,180
9606,R-HSA-2408522,Selenoamino acid metabolism,4.1104897263721796e-10,182,21,33,3
9606,R-HSA-72312,rRNA processing,7.072005203667686e-10,252,24,22,9
9606,R-HSA-72163,mRNA Splicing - Major Pathway,1.0391160154554768e-09,213,22,11,11
9606,R-HSA-9678108,SARS-CoV-1 Infection,1.257047244074272e-09,194,21,159,14
9606,R-HSA-9711097,Cellular response to starvation,1.524910864247886e-09,176,20,28,4
9606,R-HSA-69481,G2/M Checkpoints,2.424052403249277e-09,142,18,24,6
9606,R-HSA-422475,Axon guidance,2.424052403249277e-09,566,35,295,27
9606,R-HSA-72172,mRNA Splicing,2.4456985325826963e-09,224,22,16,16
9606,R-HSA-3247509,Chromatin modifying enzymes,4.339774428707699e-09,254,23,85,33
9606,R-HSA-9675108,Nervous system development,1.2166746943265139e-08,603,35,322,27
9606,R-HSA-4839726,Chromatin organization,1.2347144418001221e-08,269,23,105,33
9606,R-HSA-109581,Apoptosis,1.3534873222198485e-08,180,19,142,19
9606,R-HSA-68886,M Phase,1.521716519459204e-08,403,28,96,48
9606,R-HSA-69278,"Cell Cycle, Mitotic",2.208250482471641e-08,587,34,367,123
9606,R-HSA-9754678,SARS-CoV-2 modulates host translation machinery,2.9224143105466283e-08,62,12,6,1
9606,R-HSA-9018519,Estrogen-dependent gene expression,4.9408714897225536e-08,153,17,66,40
9606,R-HSA-162909,Host Interactions of HIV factors,7.741382013204401e-08,138,16,54,19
9606,R-HSA-5357801,Programmed Cell Death,7.741382013204401e-08,225,20,194,28
9606,R-HSA-2559586,DNA Damage/Telomere Stress Induced Senescence,1.05448610177028e-07,70,12,18,2
9606,R-HSA-9954709,Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide,1.4798802572268954e-07,106,14,13,13
9606,R-HSA-8939236,RUNX1 regulates transcription of genes involved in differentiation of HSCs,2.2135673893863839e-07,92,13,15,12
9606,R-HSA-1221632,Meiotic synapsis,2.61272595558637e-07,61,11,6,6
9606,R-HSA-9705683,SARS-CoV-2-host interactions,3.6096812938701817e-07,248,20,68,8
9606,R-HSA-201722,Formation of the beta-catenin:TCF transactivating complex,7.330778195591137e-07,68,11,13,7
9606,R-HSA-68867,Assembly of the pre-replicative complex,7.674096481613546e-07,103,13,23,12
9606,R-HSA-75153,Apoptotic execution phase,8.814009029300962e-07,54,10,57,13
9606,R-HSA-9909648,Regulation of PD-L1(CD274) expression,1.018430217158972e-06,191,17,56,20
9606,R-HSA-450408,AUF1 (hnRNP D0) binds and destabilizes mRNA,1.4022179239958632e-06,43,9,4,4
9606,R-HSA-69620,Cell Cycle Checkpoints,1.9872021326250433e-06,278,20,63,16
9606,R-HSA-68875,Mitotic Prophase,2.162235011482494e-06,134,14,34,16
9606,R-HSA-201681,TCF dependent signaling in response to WNT,2.405325529863944e-06,204,17,71,21
9606,R-HSA-9694516,SARS-CoV-2 Infection,2.7860990474692926e-06,369,23,211,12
9606,R-HSA-5625740,RHO GTPases activate PKNs,2.8491101411454167e-06,79,11,20,11
9606,R-HSA-69002,DNA Replication Pre-Initiation,4.176374874265143e-06,121,13,32,20
9606,R-HSA-9020591,Interleukin-12 signaling,5.011593160020311e-06,84,11,56,12
9606,R-HSA-9764274,Regulation of Expression and Function of Type I Classical Cadherins,5.011593160020311e-06,192,16,92,14
9606,R-HSA-9764265,Regulation of CDH1 Expression and Function,5.011593160020311e-06,192,16,92,14
9606,R-HSA-9679506,SARS-CoV Infections,5.011593160020311e-06,576,29,402,28
9606,R-HSA-446728,Cell junction organization,5.132966401033556e-06,298,20,162,23
9606,R-HSA-5693565,Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks,5.158819253114899e-06,67,10,39,30
9606,R-HSA-2990846,SUMOylation,5.254976802815392e-06,193,16,141,139
9606,R-HSA-71291,Metabolism of amino acids and derivatives,5.368387490323201e-06,646,31,293,20
9606,R-HSA-389948,Co-inhibition by PD-1,5.5864840740049715e-06,219,17,61,20
9606,R-HSA-1428517,Aerobic respiration and respiratory electron transport,6.138324012527896e-06,361,22,117,34
9606,R-HSA-774815,Nucleosome assembly,6.43970415081796e-06,53,9,4,3
9606,R-HSA-606279,Deposition of new CENPA-containing nucleosomes at the centromere,6.43970415081796e-06,53,9,4,3
9606,R-HSA-388841,Regulation of T cell activation by CD28 family,6.464410533646436e-06,276,19,91,22
9606,R-HSA-1500931,Cell-Cell communication,7.563851291636503e-06,336,21,185,24
9606,R-HSA-8939211,ESR-mediated signaling,1.0189437514185329e-05,257,18,114,47
9606,R-HSA-8950505,Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation,1.0318043931811793e-05,73,10,36,10
9606,R-HSA-9909649,Regulation of PD-L1(CD274) transcription,1.074940761336407e-05,74,10,18,9
9606,R-HSA-1500620,Meiosis,1.1096120750231364e-05,93,11,16,10
9606,R-HSA-5687128,MAPK6/MAPK4 signaling,1.1096120750231364e-05,93,11,40,13
9606,R-HSA-5693606,DNA Double Strand Break Response,1.21099194698715e-05,75,10,48,30
9606,R-HSA-3108232,SUMO E3 ligases SUMOylate target proteins,1.2836810297400802e-05,184,15,132,132
9606,R-HSA-447115,Interleukin-12 family signaling,1.5035963499610006e-05,96,11,114,13
9606,R-HSA-3899300,SUMOylation of transcription cofactors,1.5215241889743325e-05,44,8,27,27
9606,R-HSA-9645723,Diseases of programmed cell death,1.5215241889743325e-05,97,11,37,5
9606,R-HSA-9759476,Regulation of Homotypic Cell-Cell Adhesion,1.6581046773600505e-05,215,16,125,14
9606,R-HSA-450531,Regulation of mRNA stability by proteins that bind AU-rich elements,1.963160107187889e-05,80,10,26,9
9606,R-HSA-8878171,Transcriptional regulation by RUNX1,2.09415332785845e-05,246,17,132,116
9606,R-HSA-8941858,Regulation of RUNX3 expression and activity,2.321887819156654e-05,47,8,9,4
9606,R-HSA-162906,HIV Infection,2.330658389826379e-05,248,17,160,28
9606,R-HSA-69473,G2/M DNA damage checkpoint,2.4385131465631815e-05,82,10,12,3
9606,R-HSA-171306,Packaging Of Telomere Ends,2.4441746931058717e-05,33,7,2,2
9606,R-HSA-69306,DNA Replication,2.5661759005535245e-05,171,14,73,37
9606,R-HSA-2559583,Cellular Senescence,3.0310652695431095e-05,199,15,90,13
9606,R-HSA-8878159,Transcriptional regulation by RUNX3,3.817938658334796e-05,108,11,47,25
9606,R-HSA-1266738,Developmental Biology,4.1573204634381966e-05,1968,61,980,126
9606,R-HSA-9006931,Signaling by Nuclear Receptors,4.4207186418177e-05,383,21,195,51
9606,R-HSA-5693607,Processing of DNA double-strand break ends,4.52659578875636e-05,89,10,17,2
9606,R-HSA-211733,Regulation of activated PAK-2p34 by proteasome mediated degradation,4.667830283411334e-05,37,7,2,2
9606,R-HSA-1268020,Mitochondrial protein import,4.698209917552987e-05,70,9,14,12
9606,R-HSA-8852276,The role of GTSE1 in G2/M progression after G2 checkpoint,4.698209917552987e-05,70,9,10,5
9606,R-HSA-9616222,Transcriptional regulation of granulopoiesis,4.698209917552987e-05,70,9,27,6
9606,R-HSA-68882,Mitotic Anaphase,4.854967717071723e-05,236,16,32,13
9606,R-HSA-73886,Chromosome Maintenance,4.9245834353395246e-05,135,12,38,32
9606,R-HSA-2555396,Mitotic Metaphase and Anaphase,4.9245834353395246e-05,237,16,33,13
9606,R-HSA-418990,Adherens junctions interactions,4.9245834353395246e-05,238,16,141,14
9606,R-HSA-110330,Recognition and association of DNA glycosylase with site containing an affected purine,4.9896971757390496e-05,38,7,10,2
9606,R-HSA-194315,Signaling by Rho GTPases,6.342374246093296e-05,708,30,203,76
9606,R-HSA-5619507,Activation of HOX genes during differentiation,6.68277846930243e-05,116,11,43,31
9606,R-HSA-5617472,Activation of anterior HOX genes in hindbrain development during early embryogenesis,6.68277846930243e-05,116,11,43,31
9606,R-HSA-5693571,Nonhomologous End-Joining (NHEJ),6.753414620030984e-05,56,8,13,13
9606,R-HSA-5689880,Ub-specific processing proteases,7.714282874593525e-05,192,14,40,36
9606,R-HSA-8936459,RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function,8.104188400259726e-05,76,9,33,33
9606,R-HSA-110328,Recognition and association of DNA glycosylase with site containing an affected pyrimidine,8.128575752297529e-05,41,7,21,1
9606,R-HSA-169911,Regulation of Apoptosis,9.482465964738562e-05,42,7,5,4
9606,R-HSA-9716542,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",9.704040483871079e-05,724,30,212,76
9606,R-HSA-5693532,DNA Double-Strand Break Repair,9.825963782894576e-05,171,13,116,46
9606,R-HSA-68949,Orc1 removal from chromatin,9.825963782894576e-05,60,8,4,3
9606,R-HSA-9843940,Regulation of endogenous retroelements by KRAB-ZFP proteins,9.825963782894576e-05,78,9,7,7
9606,R-HSA-445355,Smooth Muscle Contraction,0.00011050478626373206,61,8,16,8
9606,R-HSA-2559584,Formation of Senescence-Associated Heterochromatin Foci (SAHF),0.00011075521922609965,17,5,2,1
9606,R-HSA-110331,Cleavage of the damaged purine,0.00011336893721480834,44,7,9,2
9606,R-HSA-5693567,HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA),0.00012684625446457432,126,11,47,3
9606,R-HSA-73927,Depurination,0.0001307572412061475,45,7,19,4
9606,R-HSA-212300,PRC2 methylates histones and DNA,0.00015029243963926575,46,7,4,4
9606,R-HSA-195258,RHO GTPase Effectors,0.00015119910371108602,325,18,113,44
9606,R-HSA-9670095,Inhibition of DNA recombination at telomere,0.00017217608559416675,47,7,4,3
9606,R-HSA-9735871,SARS-CoV-1 targets host intracellular signalling and regulatory pathways,0.00018779448017802736,19,5,7,3
9606,R-HSA-5693538,Homology Directed Repair,0.00019328702230048123,132,11,55,3
9606,R-HSA-9929491,SPOP-mediated proteasomal degradation of PD-L1(CD274),0.00019662256386077104,48,7,6,4
9606,R-HSA-421270,Cell-cell junction organization,0.00020781183636930933,271,16,146,14
9606,R-HSA-9759194,Nuclear events mediated by NFE2L2,0.00023654432596575958,135,11,85,58
9606,R-HSA-9764725,Negative Regulation of CDH1 Gene Transcription,0.00023762076663746967,68,8,42,5
9606,R-HSA-5688426,Deubiquitination,0.0002471298330277705,275,16,77,58
9606,R-HSA-9710421,Defective pyroptosis,0.00025172292769437554,51,7,3,1
9606,R-HSA-110329,Cleavage of the damaged pyrimidine ,0.00025172292769437554,50,7,20,1
9606,R-HSA-73928,Depyrimidination,0.00025172292769437554,50,7,41,2
9606,R-HSA-9918487,Dengue Virus Genome Translation and Replication,0.00027823421270223303,115,10,64,10
9606,R-HSA-8864260,Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,0.0002841955616983416,52,7,44,15
9606,R-HSA-9755511,KEAP1-NFE2L2 pathway,0.0003389663651482966,169,12,117,68
9606,R-HSA-1234174,Cellular response to hypoxia,0.0003406780915728991,73,8,20,8
9606,R-HSA-2299718,Condensation of Prophase Chromosomes,0.0003594835658157214,54,7,10,10
9606,R-HSA-180897,Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization,0.00036222952309361567,4,3,2,1
9606,R-HSA-195721,Signaling by WNT,0.00037511097678299965,320,17,157,26
9606,R-HSA-9613829,Chaperone Mediated Autophagy,0.0004038129400585344,23,5,19,15
9606,R-HSA-1474165,Reproduction,0.0004150799608250155,146,11,44,10
9606,R-HSA-157118,Signaling by NOTCH,0.0004193321052494703,260,15,165,38
9606,R-HSA-3371497,HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand,0.00044982897428669233,76,8,22,22
9606,R-HSA-9764560,Regulation of CDH1 Gene Transcription,0.0005376331087918462,78,8,56,5
9606,R-HSA-180534,Vpu mediated degradation of CD4,0.0005645377419384312,40,6,5,2
9606,R-HSA-5250913,Positive epigenetic regulation of rRNA expression,0.0005866010708921454,79,8,7,6
9606,R-HSA-390450,Folding of actin by CCT/TriC,0.0006095057967672179,13,4,2,2
9606,R-HSA-140342,Apoptosis induced DNA fragmentation,0.0006095057967672179,13,4,12,2
9606,R-HSA-5358346,Hedgehog ligand biogenesis,0.0006212026772991486,59,7,15,4
9606,R-HSA-8854050,FBXL7 down-regulates AURKA during mitotic entry and in early mitosis,0.0006301296170705406,42,6,6,4
9606,R-HSA-174113,SCF-beta-TrCP mediated degradation of Emi1,0.0006301296170705406,42,6,3,2
9606,R-HSA-69052,Switching of origins to a post-replicative state,0.0006301296170705406,81,8,10,6
9606,R-HSA-75815,Ubiquitin-dependent degradation of Cyclin D,0.0006301296170705406,41,6,5,2
9606,R-HSA-349425,Autodegradation of the E3 ubiquitin ligase COP1,0.0006301296170705406,41,6,5,2
9606,R-HSA-9013694,Signaling by NOTCH4,0.0006481682640746556,82,8,20,3
9606,R-HSA-5250924,B-WICH complex positively regulates rRNA expression,0.000653100132704143,61,7,3,3
9606,R-HSA-1852241,Organelle biogenesis and maintenance,0.0006636196983873521,340,17,86,16
9606,R-HSA-9609690,HCMV Early Events,0.0007040252757473109,215,13,12,8
9606,R-HSA-180585,Vif-mediated degradation of APOBEC3G,0.0007153548872862459,43,6,4,2
9606,R-HSA-73929,"Base-Excision Repair, AP Site Formation",0.0007212554844611141,62,7,64,6
9606,R-HSA-5627123,RHO GTPases activate PAKs,0.0007295728642060517,27,5,15,12
9606,R-HSA-5689603,UCH proteinases,0.0007631595605874786,84,8,11,7
9606,R-HSA-212165,Epigenetic regulation of gene expression,0.0007879390542457898,345,17,118,74
9606,R-HSA-157579,Telomere Maintenance,0.0007927561374820868,108,9,34,29
9606,R-HSA-3214815,HDACs deacetylate histones,0.0007950765668454096,63,7,5,5
9606,R-HSA-4641257,Degradation of AXIN,0.0008094785689862771,44,6,8,4
9606,R-HSA-9762114,GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,0.0008094785689862771,44,6,4,2
9606,R-HSA-4641258,Degradation of DVL,0.0008094785689862771,44,6,7,4
9606,R-HSA-3371556,Cellular response to heat stress,0.0008784955726051091,135,10,29,15
9606,R-HSA-5578749,Transcriptional regulation by small RNAs,0.0009599345057681452,46,6,5,2
9606,R-HSA-449147,Signaling by Interleukins,0.0009599345057681452,646,25,505,34
9606,R-HSA-69541,Stabilization of p53,0.0009599345057681452,46,6,15,4
9606,R-HSA-70171,Glycolysis,0.0009599345057681452,111,9,23,7
9606,R-HSA-2995410,Nuclear Envelope (NE) Reassembly,0.0009599345057681452,88,8,24,8
9606,R-HSA-9604323,Negative regulation of NOTCH4 signaling,0.0009599345057681452,47,6,6,2
9606,R-HSA-9764561,Regulation of CDH1 Function,0.0009599345057681452,65,7,16,6
9606,R-HSA-9711123,Cellular response to chemical stress,0.0009599345057681452,288,15,173,72
9606,R-HSA-177243,Interactions of Rev with host cellular proteins,0.0009599345057681452,47,6,16,12
9606,R-HSA-69242,S Phase,0.0009599345057681452,166,11,55,26
9606,R-HSA-427389,ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression,0.0009599345057681452,47,6,4,3
9606,R-HSA-3371568,Attenuation phase,0.0009599345057681452,47,6,5,4
9606,R-HSA-9842860,Regulation of endogenous retroelements,0.0009599345057681452,113,9,17,14
9606,R-HSA-9818564,Epigenetic regulation of gene expression by MLL3 and MLL4 complexes,0.0009599345057681452,139,10,40,34
9606,R-HSA-9851695,Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes,0.0009599345057681452,139,10,37,33
9606,R-HSA-9841922,MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis,0.0009599345057681452,139,10,37,33
9606,R-HSA-9929356,GSK3B-mediated proteasomal degradation of PD-L1(CD274),0.0009599345057681452,46,6,7,3
9606,R-HSA-69206,G1/S Transition,0.0009772999785900849,140,10,61,13
9606,R-HSA-9821993,Replacement of protamines by nucleosomes in the male pronucleus,0.000987282493923325,30,5,6,1
9606,R-HSA-389960,Formation of tubulin folding intermediates by CCT/TriC,0.000987282493923325,30,5,2,2
9606,R-HSA-5676590,NIK-->noncanonical NF-kB signaling,0.0010737117106318639,48,6,9,2
9606,R-HSA-5625886,Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3,0.0010737117106318639,48,6,11,9
9606,R-HSA-5362768,Hh mutants are degraded by ERAD,0.0010737117106318639,48,6,6,2
9606,R-HSA-73856,RNA Polymerase II Transcription Termination,0.0011478487047333896,69,7,4,2
9606,R-HSA-8939902,Regulation of RUNX2 expression and activity,0.0011478487047333896,69,7,29,13
9606,R-HSA-9793380,Formation of paraxial mesoderm,0.0011478487047333896,69,7,29,3
9606,R-HSA-9917777,Epigenetic regulation by WDR5-containing histone modifying complexes,0.001158041170536972,171,11,67,36
9606,R-HSA-9609507,Protein localization,0.001158041170536972,171,11,53,27
9606,R-HSA-9932298,Degradation of CRY and PER proteins,0.0011978554249186812,49,6,9,6
9606,R-HSA-5610780,Degradation of GLI1 by the proteasome,0.0011978554249186812,49,6,6,3
9606,R-HSA-5610785,GLI3 is processed to GLI3R by the proteasome,0.0011978554249186812,49,6,5,2
9606,R-HSA-5610783,Degradation of GLI2 by the proteasome,0.0011978554249186812,49,6,5,2
9606,R-HSA-4615885,SUMOylation of DNA replication proteins,0.0013330224475999186,50,6,8,8
9606,R-HSA-3065678,"SUMO is transferred from E1 to E2 (UBE2I, UBC9)",0.0013345625203142752,7,3,3,3
9606,R-HSA-69239,Synthesis of DNA,0.001343191717775305,119,9,27,17
9606,R-HSA-69275,G2/M Transition,0.0014262475876086755,205,12,88,24
9606,R-HSA-5387390,Hh mutants abrogate ligand secretion,0.0014798914714264644,51,6,7,2
9606,R-HSA-8949613,Cristae formation,0.0015247301202508945,33,5,2,2
9606,R-HSA-73728,RNA Polymerase I Promoter Opening,0.0015247301202508945,33,5,2,1
9606,R-HSA-70268,Pyruvate metabolism,0.0015512872436151959,96,8,31,12
9606,R-HSA-453274,Mitotic G2-G2/M phases,0.0015548517172125909,207,12,90,24
9606,R-HSA-187577,SCF(Skp2)-mediated degradation of p27/p21,0.001639162892977386,52,6,7,2
9606,R-HSA-5678895,Defective CFTR causes cystic fibrosis,0.001811558592370588,53,6,8,3
9606,R-HSA-4608870,Asymmetric localization of PCP proteins,0.001811558592370588,53,6,7,2
9606,R-HSA-5607761,Dectin-1 mediated noncanonical NF-kB signaling,0.001811558592370588,53,6,9,2
9606,R-HSA-69601,Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A,0.001811558592370588,53,6,11,2
9606,R-HSA-69613,p53-Independent G1/S DNA Damage Checkpoint,0.001811558592370588,53,6,11,2
9606,R-HSA-399954,Sema3A PAK dependent Axon repulsion,0.001831819818025604,19,4,6,6
9606,R-HSA-73884,Base Excision Repair,0.0018987215674926006,99,8,107,12
9606,R-HSA-69202,Cyclin E associated events during G1/S transition ,0.00190080791187075,78,7,20,4
9606,R-HSA-1912408,Pre-NOTCH Transcription and Translation,0.00190080791187075,100,8,37,9
9606,R-HSA-1168372,Downstream signaling events of B Cell Receptor (BCR),0.00190080791187075,78,7,15,4
9606,R-HSA-174154,APC/C:Cdc20 mediated degradation of Securin,0.00190080791187075,55,6,3,2
9606,R-HSA-174084,Autodegradation of Cdh1 by Cdh1:APC/C,0.00190080791187075,54,6,2,2
9606,R-HSA-5334118,DNA methylation,0.00190080791187075,35,5,7,7
9606,R-HSA-389958,Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding,0.0020439642911589395,37,5,6,5
9606,R-HSA-9766229,Degradation of CDH1,0.002118047131852041,57,6,10,3
9606,R-HSA-69563,p53-Dependent G1 DNA Damage Response,0.002118047131852041,57,6,22,4
9606,R-HSA-69580,p53-Dependent G1/S DNA damage checkpoint,0.002118047131852041,57,6,22,4
9606,R-HSA-77595,Processing of Intronless Pre-mRNAs,0.0021287539929555344,21,4,5,5
9606,R-HSA-70326,Glucose metabolism,0.0021355251262944464,131,9,40,12
9606,R-HSA-1592230,Mitochondrial biogenesis,0.0021355251262944464,131,9,36,5
9606,R-HSA-69656,Cyclin A:Cdk2-associated events at S phase entry,0.0022045005019730723,80,7,19,3
9606,R-HSA-9818749,Regulation of NFE2L2 gene expression,0.0022120649666121928,9,3,7,4
9606,R-HSA-111465,Apoptotic cleavage of cellular proteins,0.002303173395842073,38,5,38,7
9606,R-HSA-350562,Regulation of ornithine decarboxylase (ODC),0.002303173395842073,38,5,3,1
9606,R-HSA-5658442,Regulation of RAS by GAPs,0.002317709656718847,58,6,5,2
9606,R-HSA-3371571,HSF1-dependent transactivation,0.0025316848035812356,59,6,8,5
9606,R-HSA-912446,Meiotic recombination,0.0025316848035812356,59,6,10,4
9606,R-HSA-1234176,Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha,0.0025316848035812356,59,6,12,4
9606,R-HSA-1169091,Activation of NF-kappaB in B cells,0.0025316848035812356,59,6,10,2
9606,R-HSA-6804758,Regulation of TP53 Activity through Acetylation,0.002586295345506251,39,5,14,8
9606,R-HSA-68616,Assembly of the ORC complex at the origin of replication,0.002586295345506251,39,5,11,2
9606,R-HSA-453279,Mitotic G1 phase and G1/S transition,0.0026588096538033845,164,10,101,14
9606,R-HSA-597592,Post-translational protein modification,0.002706773646110605,1680,47,606,295
9606,R-HSA-8852135,Protein ubiquitination,0.002731145227143017,83,7,32,29
9606,R-HSA-71403,Citric acid cycle (TCA cycle),0.002731145227143017,83,7,23,11
9606,R-HSA-9931269,AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274),0.0027606635615997632,60,6,5,3
9606,R-HSA-174184,Cdc20:Phospho-APC/C mediated degradation of Cyclin A,0.0027606635615997632,60,6,3,2
9606,R-HSA-8866654,E3 ubiquitin ligases ubiquitinate target proteins,0.0027606635615997632,60,6,16,16
9606,R-HSA-5336415,Uptake and function of diphtheria toxin,0.002996022334350812,10,3,5,2
9606,R-HSA-174178,APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1,0.003005351910291054,61,6,6,4
9606,R-HSA-179419,APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint,0.003005351910291054,61,6,6,4
9606,R-HSA-8948751,Regulation of PTEN stability and activity,0.003005351910291054,61,6,13,6
9606,R-HSA-6798695,Neutrophil degranulation,0.003058097768003254,478,19,10,6
9606,R-HSA-211000,Gene Silencing by RNA,0.0031343696535910404,85,7,40,5
9606,R-HSA-9843970,Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex,0.003229792708628665,41,5,8,5
9606,R-HSA-69017,CDK-mediated phosphorylation and removal of Cdc6,0.0032664704581453208,62,6,4,2
9606,R-HSA-1280215,Cytokine Signaling in Immune system,0.0034444732720175786,1106,34,806,56
9606,R-HSA-176409,APC/C:Cdc20 mediated degradation of mitotic proteins,0.003544754064582989,63,6,13,8
9606,R-HSA-2559580,Oxidative Stress Induced Senescence,0.003563782864648868,113,8,40,8
9606,R-HSA-176814,Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins,0.0038409514460684413,64,6,15,8
9606,R-HSA-8939246,RUNX1 regulates transcription of genes involved in differentiation of myeloid cells,0.0039373355755984996,11,3,7,7
9606,R-HSA-9609646,HCMV Infection,0.00394476298372437,270,13,31,11
9606,R-HSA-163210,Formation of ATP by chemiosmotic coupling,0.004051611055495119,25,4,3,3
9606,R-HSA-5620922,BBSome-mediated cargo-targeting to cilium,0.004051611055495119,25,4,5,1
9606,R-HSA-2980766,Nuclear Envelope Breakdown,0.004155824767161143,65,6,13,5
9606,R-HSA-73894,DNA Repair,0.004398658079708184,380,16,342,131
9606,R-HSA-427359,SIRT1 negatively regulates rRNA expression,0.0044094848424318656,44,5,5,3
9606,R-HSA-176408,Regulation of APC/C activators between G1/S and early anaphase,0.004752129945094441,70,6,14,2
9606,R-HSA-1236978,Cross-presentation of soluble exogenous antigens (endosomes),0.004752129945094441,46,5,7,2
9606,R-HSA-9909615,Regulation of PD-L1(CD274) Post-translational modification,0.004752129945094441,94,7,25,11
9606,R-HSA-9909396,Circadian clock,0.004752129945094441,148,9,78,38
9606,R-HSA-176033,Interactions of Vpr with host cellular proteins,0.004752129945094441,47,5,4,2
9606,R-HSA-8866907,Activation of the TFAP2 (AP-2) family of transcription factors,0.004752129945094441,12,3,4,2
9606,R-HSA-264870,Caspase-mediated cleavage of cytoskeletal proteins,0.004752129945094441,12,3,10,5
9606,R-HSA-2995383,Initiation of Nuclear Envelope (NE) Reformation,0.004752129945094441,27,4,7,2
9606,R-HSA-352238,Breakdown of the nuclear lamina,0.004752129945094441,3,2,3,2
9606,R-HSA-165054,Rev-mediated nuclear export of HIV RNA,0.004752129945094441,45,5,10,7
9606,R-HSA-3215018,Processing and activation of SUMO,0.004752129945094441,13,3,9,7
9606,R-HSA-9646399,Aggrephagy,0.004752129945094441,47,5,15,13
9606,R-HSA-9845323,Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs),0.004752129945094441,68,6,2,2
9606,R-HSA-2467813,Separation of Sister Chromatids,0.004752129945094441,182,10,8,5
9606,R-HSA-9793242,SUMOylation of nuclear envelope proteins,0.004752129945094441,3,2,1,1
9606,R-HSA-9636667,Manipulation of host energy metabolism,0.004752129945094441,3,2,2,2
9606,R-HSA-9821002,Chromatin modifications during the maternal to zygotic transition (MZT),0.004833398751348361,48,5,12,6
9606,R-HSA-69615,G1/S DNA Damage Checkpoints,0.004861144295427278,71,6,33,6
9606,R-HSA-373755,Semaphorin interactions,0.004861144295427278,71,6,41,7
9606,R-HSA-9663891,Selective autophagy,0.004981157568422434,97,7,56,32
9606,R-HSA-1912422,Pre-NOTCH Expression and Processing,0.005027801799823761,125,8,47,9
9606,R-HSA-389957,Prefoldin mediated transfer of substrate  to CCT/TriC,0.005214271500535772,29,4,2,1
9606,R-HSA-1236974,ER-Phagosome pathway,0.005275234773524873,98,7,11,4
9606,R-HSA-74160,Gene expression (Transcription),0.005641612368047055,1958,51,1139,362
9606,R-HSA-8862803,Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,0.005892006829588792,30,4,22,4
9606,R-HSA-75067,Processing of Capped Intronless Pre-mRNA,0.005892006829588792,30,4,10,5
9606,R-HSA-8863678,Neurodegenerative Diseases,0.005892006829588792,30,4,22,4
9606,R-HSA-5621481,C-type lectin receptors (CLRs),0.005900035718840235,190,10,68,12
9606,R-HSA-1169410,Antimicrobial mechanism of IFN-stimulated genes,0.006359665612467369,192,10,86,10
9606,R-HSA-9907900,Proteasome assembly,0.006822831216980241,52,5,40,28
9606,R-HSA-9818028,NFE2L2 regulates pentose phosphate pathway genes,0.007117432292388148,15,3,8,4
9606,R-HSA-8878166,Transcriptional regulation by RUNX2,0.007348278424804788,133,8,81,42
9606,R-HSA-9824272,Somitogenesis,0.007401317933239726,53,5,19,1
9606,R-HSA-9865118,Diseases of branched-chain amino acid catabolism,0.007425769235831381,32,4,11,7
9606,R-HSA-195253,Degradation of beta-catenin by the destruction complex,0.007737884226428404,78,6,23,3
9606,R-HSA-9861718,Regulation of pyruvate metabolism,0.00801461943839099,54,5,11,4
9606,R-HSA-9856649,Transcriptional and post-translational regulation of MITF-M expression and activity,0.008234994693988362,79,6,37,7
9606,R-HSA-427413,NoRC negatively regulates rRNA expression,0.008234994693988362,79,6,7,4
9606,R-HSA-174143,APC/C-mediated degradation of cell cycle proteins,0.008234994693988362,79,6,40,16
9606,R-HSA-453276,Regulation of mitotic cell cycle,0.008234994693988362,79,6,40,16
9606,R-HSA-5632684,Hedgehog 'on' state,0.008234994693988362,79,6,37,5
9606,R-HSA-9734009,Defective Intrinsic Pathway for Apoptosis,0.008286746565869252,33,4,24,4
9606,R-HSA-8951936,RUNX3 regulates p14-ARF,0.00852927711180762,16,3,8,8
9606,R-HSA-5607764,CLEC7A (Dectin-1) signaling,0.008570365622239673,107,7,45,9
9606,R-HSA-9816359,Maternal to zygotic transition (MZT),0.008786315887871265,137,8,46,15
9606,R-HSA-70263,Gluconeogenesis,0.009350413960995452,56,5,17,5
9606,R-HSA-8877330,RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs),0.010101979219052537,17,3,20,20
9606,R-HSA-75035,Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex,0.010101979219052537,17,3,5,1
9606,R-HSA-73854,RNA Polymerase I Promoter Clearance,0.01108761861350771,84,6,10,3
9606,R-HSA-9706574,RHOBTB GTPase Cycle,0.011275067323214927,36,4,4,3
9606,R-HSA-73864,RNA Polymerase I Transcription,0.012412880220801892,86,6,14,3
9606,R-HSA-5619084,ABC transporter disorders,0.012412880220801892,86,6,23,3
9606,R-HSA-4086400,PCP/CE pathway,0.012412880220801892,86,6,24,2
9606,R-HSA-73772,RNA Polymerase I Promoter Escape,0.012491990108414619,60,5,2,1
9606,R-HSA-111447,Activation of BAD and translocation to mitochondria ,0.013751484714667028,19,3,5,2
9606,R-HSA-8876725,Protein methylation,0.013751484714667028,19,3,9,3
9606,R-HSA-446353,Cell-extracellular matrix interactions,0.013751484714667028,19,3,10,3
9606,R-HSA-9755779,SARS-CoV-2 targets host intracellular signalling and regulatory pathways,0.013751484714667028,19,3,5,1
9606,R-HSA-5250941,Negative epigenetic regulation of rRNA expression,0.013851780483225329,88,6,12,7
9606,R-HSA-4551638,SUMOylation of chromatin organization proteins,0.01431667109662027,62,5,15,15
9606,R-HSA-977225,Amyloid fiber formation,0.01461559957454217,89,6,33,6
9606,R-HSA-4085377,SUMOylation of SUMOylation proteins,0.014920366369765348,39,4,5,5
9606,R-HSA-8941333,RUNX2 regulates genes involved in differentiation of myeloid cells,0.015008530345012705,6,2,2,2
9606,R-HSA-9818035,NFE2L2 regulating ER-stress associated genes,0.015008530345012705,6,2,2,2
9606,R-HSA-72202,Transport of Mature Transcript to Cytoplasm,0.015409934993597774,90,6,13,13
9606,R-HSA-2559582,Senescence-Associated Secretory Phenotype (SASP),0.015409934993597774,90,6,22,3
9606,R-HSA-73857,RNA Polymerase II Transcription,0.015624662389210453,1715,44,940,280
9606,R-HSA-3232118,SUMOylation of transcription factors,0.01583800424973314,20,3,11,11
9606,R-HSA-1236975,Antigen processing-Cross presentation,0.01586471547556534,120,7,25,6
9606,R-HSA-5668541,TNFR2 non-canonical NF-kB pathway,0.01623548960654675,91,6,44,7
9606,R-HSA-390522,Striated Muscle Contraction,0.016291908277774936,40,4,4,4
9606,R-HSA-390471,Association of TriC/CCT with target proteins during biosynthesis,0.016291908277774936,40,4,2,2
9606,R-HSA-5696399,Global Genome Nucleotide Excision Repair (GG-NER),0.01709296587207798,92,6,20,15
9606,R-HSA-202403,TCR signaling,0.0173070762892793,122,7,52,5
9606,R-HSA-6814122,Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding,0.017745238808237196,41,4,11,8
9606,R-HSA-180746,Nuclear import of Rev protein,0.017745238808237196,41,4,7,6
9606,R-HSA-6804114,TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest,0.018104845073894094,21,3,11,7
9606,R-HSA-6807070,PTEN Regulation,0.01883769876951369,156,8,56,11
9606,R-HSA-8939247,RUNX1 regulates transcription of genes involved in interleukin signaling,0.020198030272844725,7,2,5,5
9606,R-HSA-8939245,RUNX1 regulates transcription of genes involved in BCR signaling,0.020198030272844725,7,2,4,4
9606,R-HSA-9818026,NFE2L2 regulating inflammation associated genes,0.020198030272844725,7,2,3,3
9606,R-HSA-3134973,LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production,0.020198030272844725,7,2,5,1
9606,R-HSA-379724,tRNA Aminoacylation,0.020917857908791082,68,5,42,13
9606,R-HSA-351202,Metabolism of polyamines,0.020917857908791082,68,5,17,1
9606,R-HSA-196757,Metabolism of folate and pterines,0.022616298339277363,44,4,31,9
9606,R-HSA-4419969,Depolymerization of the Nuclear Lamina,0.023194646422638687,23,3,6,2
9606,R-HSA-397014,Muscle contraction,0.02334564301280173,232,10,53,12
9606,R-HSA-202424,Downstream TCR signaling,0.0240478419942739,99,6,24,4
9606,R-HSA-1430728,Metabolism,0.02547857272647036,3775,83,2376,180
9606,R-HSA-9013418,RHOBTB2 GTPase cycle,0.026024288373655446,24,3,2,2
9606,R-HSA-5627117,RHO GTPases Activate ROCKs,0.026024288373655446,24,3,7,3
9606,R-HSA-3065676,SUMO is conjugated to E1 (UBA2:SAE1),0.026084179488035653,8,2,3,3
9606,R-HSA-8937144,Aryl hydrocarbon receptor signalling,0.026084179488035653,8,2,5,3
9606,R-HSA-8935964,RUNX1 regulates expression of components of tight junctions,0.026084179488035653,8,2,6,6
9606,R-HSA-159231,Transport of Mature mRNA Derived from an Intronless Transcript,0.02630890544704456,46,4,3,3
9606,R-HSA-159234,Transport of Mature mRNAs Derived from Intronless Transcripts,0.028294273566499495,47,4,9,9
9606,R-HSA-3214841,PKMTs methylate histone lysines,0.030374651813894538,48,4,22,7
9606,R-HSA-8869496,TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation,0.032641755298399966,9,2,7,7
9606,R-HSA-8939256,RUNX1 regulates transcription of genes involved in WNT signaling,0.032641755298399966,9,2,4,4
9606,R-HSA-9918432,Maturation of DENV proteins,0.03441472880104135,77,5,41,5
9606,R-HSA-9612973,Autophagy,0.03477125986854945,174,8,117,49
9606,R-HSA-379716,Cytosolic tRNA aminoacylation,0.03482696621753645,50,4,21,12
9606,R-HSA-9610379,HCMV Late Events,0.035880316553577596,175,8,19,3
9606,R-HSA-1445148,Translocation of SLC2A4 (GLUT4) to the plasma membrane,0.036534114376152615,81,5,15,4
9606,R-HSA-5663202,Diseases of signal transduction by growth factor receptors and second messengers,0.036534114376152615,536,17,516,135
9606,R-HSA-5610787,Hedgehog 'off' state,0.036534114376152615,111,6,32,7
9606,R-HSA-5621575,CD209 (DC-SIGN) signaling,0.036534114376152615,30,3,11,3
9606,R-HSA-9637690,Response of Mtb to phagocytosis,0.036534114376152615,52,4,30,5
9606,R-HSA-382556,ABC-family proteins mediated transport,0.036534114376152615,111,6,27,3
9606,R-HSA-5620920,Cargo trafficking to the periciliary membrane,0.036534114376152615,79,5,29,3
9606,R-HSA-9020702,Interleukin-1 signaling,0.036534114376152615,112,6,59,12
9606,R-HSA-9700206,Signaling by ALK in cancer,0.036534114376152615,119,6,71,36
9606,R-HSA-3108214,SUMOylation of DNA damage response and repair proteins,0.036534114376152615,81,5,24,24
9606,R-HSA-2122947,NOTCH1 Intracellular Domain Regulates Transcription,0.036534114376152615,57,4,18,12
9606,R-HSA-8939242,RUNX1 regulates transcription of genes involved in differentiation of keratinocytes,0.036534114376152615,11,2,8,6
9606,R-HSA-5696398,Nucleotide Excision Repair,0.036534114376152615,117,6,37,28
9606,R-HSA-8931987,RUNX1 regulates estrogen receptor mediated transcription,0.036534114376152615,10,2,8,7
9606,R-HSA-159236,Transport of Mature mRNA derived from an Intron-Containing Transcript,0.036534114376152615,81,5,4,4
9606,R-HSA-9725370,Signaling by ALK fusions and activated point mutants,0.036534114376152615,119,6,63,35
9606,R-HSA-4570464,SUMOylation of RNA binding proteins,0.036534114376152615,51,4,4,4
9606,R-HSA-6803529,FGFR2 alternative splicing,0.036534114376152615,28,3,4,4
9606,R-HSA-1655829,Regulation of cholesterol biosynthesis by SREBP (SREBF),0.0368481801424847,87,5,52,6
9606,R-HSA-9615933,Postmitotic nuclear pore complex (NPC) reformation,0.037205434617712196,32,3,10,5
9606,R-HSA-9820952,Respiratory Syncytial Virus Infection Pathway,0.03731705547316011,154,7,101,11
9606,R-HSA-9818032,NFE2L2 regulating MDR associated enzymes,0.037400362028448875,12,2,8,8
9606,R-HSA-176974,Unwinding of DNA,0.037400362028448875,12,2,4,2
9606,R-HSA-9834752,Respiratory syncytial virus genome replication,0.037400362028448875,12,2,5,1
9606,R-HSA-5358351,Signaling by Hedgehog,0.03849611012191545,155,7,82,16
9606,R-HSA-70895,Branched-chain amino acid catabolism,0.039970019567781234,59,4,25,8
9606,R-HSA-2151201,Transcriptional activation of mitochondrial biogenesis,0.04017245411916148,89,5,32,3
9606,R-HSA-83936,Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane,0.040297976774351874,33,3,16,3
9606,R-HSA-9841251,Mitochondrial unfolded protein response (UPRmt),0.040297976774351874,33,3,21,3
9606,R-HSA-1632852,Macroautophagy,0.04218948716952298,158,7,96,32
9606,R-HSA-168256,Immune System,0.04304428270171812,2800,62,1822,205
9606,R-HSA-9820962,Assembly and release of respiratory syncytial virus (RSV) virions,0.04340297717533015,13,2,4,1
9606,R-HSA-9615710,Late endosomal microautophagy,0.04689542098193322,35,3,3,3
9606,R-HSA-6811436,COPI-independent Golgi-to-ER retrograde traffic,0.04929959417980134,63,4,7,4
9606,R-HSA-9614399,Regulation of localization of FOXO transcription factors,0.049775483461479864,14,2,5,2
9606,R-HSA-163765,ChREBP activates metabolic gene expression,0.049775483461479864,14,2,13,2
